According to the most recent financial data from March 2026, the EPS for the trailing twelve months is $9.39. Humana's EPS for 2025 amounted to $9.87, marking a drop from $10.01 in 2024. During the quarterly period ending on Mar 31, 2026, HUM's EPS stood at $9.85.
Humana had an annual EPS of $9.87, indicating a drop of 1.4% from $10.01 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $9.85, indicating a 4.5% decrease from the same quarter last year. HUM's 12-month EPS stands at $9.39 as of March 2026. Humana's annual EPS in 2024 stood at $10.01, a 50.2% decrease year-over-year.
Humana has registered a decrease in EPS of 4.5% during the last 12 months (YoY, quarterly). In the last three years, HUM recorded an average annual EPS growth rate of -23.7%. Humana had an average annual EPS growth rate of -17.3% during the last 5 years. Across the last decade, HUM had an average annual EPS growth of 1.5%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| CI Cigna Corp | 11.92 | 82.3% | 1% | -0.7% |
| UNH Unitedhealth Group Inc | 30.72 | -15.1% | -14.8% | -3.9% |
| HUM Humana Inc | 38.25 | -1.4% | -23.7% | -17.3% |
| MOH Molina Healthcare Inc | 53.88 | -56.5% | -13.3% | -4.8% |
| CNC Centene Corp | N/A | -313.7% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.